Data / Form D filings / Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc.: Form D filings
Processa Pharmaceuticals, Inc., a pharmaceuticals company in Hanover, MD, filed 16 Form D notices with the SEC between 2011 and 2021. The latest, on February 19, 2021, reports $10.2 million sold of a $10.2 million offering to 18 investors.
Find out what Processa Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7380 COCA COLA DRIVE, SUITE 106, Hanover, MD, 21076
- Phone
- (443) 776-3133
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1533743
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2021 | New notice | $10,238,773 | $10,238,773 | $0 | 18 | Feb 16, 2021 | sec.gov |
| May 16, 2018 | New notice | $8,000,000 | $2,525,694 | $5,474,306 | 33 | May 15, 2018 | sec.gov |
| Dec 27, 2017 | Amendment | $2,580,000 | $2,580,000 | $0 | 23 | Oct 4, 2017 | sec.gov |
| Dec 5, 2017 | New notice | $2,580,000 | $2,580,000 | $0 | 23 | Oct 4, 2017 | sec.gov |
| Mar 24, 2015 | New notice | $25,500 | $25,500 | $0 | 3 | Mar 24, 2015 | sec.gov |
| Feb 20, 2015 | New notice | $2,000,000 | $90,000 | $1,910,000 | 3 | Feb 5, 2015 | sec.gov |
| Nov 13, 2014 | New notice | $75,000 | $75,000 | $0 | 1 | Oct 9, 2014 | sec.gov |
| Oct 27, 2014 | New notice | $6,388,912 | $173,825 | $6,215,087 | 15 | Oct 6, 2014 | sec.gov |
| Jan 13, 2014 | New notice | $175,000 | $175,000 | $0 | 6 | Jan 8, 2014 | sec.gov |
| Jan 10, 2014 | New notice | $1,000,000 | $250,000 | $750,000 | 1 | Jan 6, 2014 | sec.gov |
| Sep 30, 2013 | Amendment | $4,950,000 | $2,182,944 | $2,767,056 | 51 | Jul 15, 2013 | sec.gov |
| Jul 12, 2013 | New notice | $5,400,000 | $0 | $5,400,000 | 0 | Yet to occur | sec.gov |
| Jun 24, 2013 | New notice | $4,500,000 | $0 | $4,500,000 | 0 | Yet to occur | sec.gov |
| May 28, 2013 | New notice | $1,000,000 | $1,000,000 | $0 | 7 | May 22, 2013 | sec.gov |
| Aug 10, 2012 | New notice | $1,520,000 | $1,520,000 | $0 | 44 | Aug 6, 2012 | sec.gov |
| Oct 28, 2011 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Young | Executive Officer, Director | |
| Patrick Lin | Executive Officer | |
| Justin W. Yorke | Director | |
| Virgil W. Thompson | Director | |
| Michael W. Floyd | Executive Officer | |
| Wendy W. Guy | Executive Officer | |
| Khalid W. Islam | Director | |
| Geraldine W. Pannu | Director | |
| James W. Stanker | Executive Officer | |
| Sian W. Bigora | Executive Officer |
Every Form D from the week of Feb 15, 2021 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Processa Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.